24 results
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table ... #NEJM
Features of Noninferiority Studies #EBM #Noninferiority #Features #Table #NEJM
Noninferiority Studies #EBM ... Noninferiority #Features #Table ... #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Care TRICC - NEJM ... 1999 - ICU FOCUS ... - NEJM 2011 - Hip ... UGIB TRISS - NEJM ... /vmoitra) #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Differential Diagnosis of Jaundice, Presentation Pattern #Diagnosis #EM #IM #GI #Jaundice #Pattern #LFTs #Workup #Table #Differential
Pattern #Diagnosis #EM ... #IM #GI #Jaundice ... #LFTs #Workup #Table
â–º
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Pathophys #Management #EM ... #IM #PCC #Catecholamine ... #Comparison #Table
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
The arrows point to a subendocardial region with poor contrast enhancement due to ischemia. This is
This is posterior ... #Clinical #EM #IM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM